Trial reportClinical trials (London, England)2023
Informative cluster size in cluster-randomised trials: A case study from the TRIGGER trial.
Trial report in Clinical trials (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 19 citations in OpenAlex.
- What is estimated in cluster randomized crossover trials with informative sizes? A survey of estimands and common estimators.Statistical methods in medical research · 2026Article
- Confidence interval estimation for the win probability in cluster randomized trials with hierarchical composite endpoints using win fractions.Clinical trials (London, England) · 2026Article
- Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual- and Cluster-Randomized Trials.Statistics in medicine · 2026Article
- Connect Kits for Family Action: Intervention Development and Exploratory Data Analysis of Proximal Outcomes.Journal of child & adolescent substance use · 2026Article
- Model-robust standardization in stepped wedge cluster randomized trials.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2026Article
- Use of estimands in cluster randomised trials: A review.Clinical trials (London, England) · 2026Review
- International Medical Graduates Representation at International Oncology Conference Meetings: An Analysis of ASCO Annual Meetings.JCO oncology practice · 2026Article
- Estimands and Doubly Robust Estimation for Cluster-Randomized Trials With Survival Outcomes.Statistics in medicine · 2026Article
- On the mixed-model analysis of covariance in cluster-randomized trials.Statistical science : a review journal of the Institute of Mathematical Statistics · 2026Article
- Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual- and Cluster-Level Dropout.Statistics in medicine · 2025Article
- How Should Parallel Cluster Randomized Trials With a Baseline Period be Analyzed?-A Survey of Estimands and Common Estimators.Biometrical journal. Biometrische Zeitschrift · 2025Article
- Weighted Repeated Measures Correlation Coefficient: A New Correlation Coefficient for Handling Missing Data With Repeated Measures.Statistics in medicine · 2025Article
- Can the Unit Size Predict Outcomes? Testing for Informativeness in Three-Level Designs.Statistics in medicine · 2025Article
- Design of field trials for the evaluation of transmissible vaccines in animal populations.PLoS computational biology · 2025Article
- Article
- Statistical analysis plan for the NU IMPACT stepped-wedge cluster randomized trial.Contemporary clinical trials · 2024Article
- Demystifying estimands in cluster-randomised trials.Statistical methods in medical research · 2024Article
- An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size.Pharmaceutical statisticsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 3 countries.
Funding
Abstract
backgroundRecent work has shown that cluster-randomised trials can estimate two distinct estimands: the participant-average and cluster-average treatment effects. These can differ when participant outcomes or the treatment effect depends on the cluster size (termed informative cluster size). In this case, estimators that target one estimand (such as the analysis of unweighted cluster-level summaries, which targets the cluster-average effect) may be biased for the other. Furthermore, commonly used estimators such as mixed-effects models or generalised estimating equations with an exchangeable correlation structure can be biased for both estimands. However, there has been little empirical research into whether informative cluster size is likely to occur in practice.
methodWe re-analysed a cluster-randomised trial comparing two different thresholds for red blood cell transfusion in patients with acute upper gastrointestinal bleeding to explore whether estimates for the participant- and cluster-average effects differed, to provide empirical evidence for whether informative cluster size may be present. For each outcome, we first estimated a participant-average effect using independence estimating equations, which are unbiased under informative cluster size. We then compared this to two further methods: (1) a cluster-average effect estimated using either weighted independence estimating equations or unweighted cluster-level summaries, and (2) estimates from a mixed-effects model or generalised estimating equations with an exchangeable correlation structure. We then performed a small simulation study to evaluate whether observed differences between cluster- and participant-average estimates were likely to occur even if no informative cluster size was present.
resultsFor most outcomes, treatment effect estimates from different methods were similar. However, differences of >10% occurred between participant- and cluster-average estimates for 5 of 17 outcomes (29%). We also observed several notable differences between estimates from mixed-effects models or generalised estimating equations with an exchangeable correlation structure and those based on independence estimating equations. For example, for the EQ-5D VAS score, the independence estimating equation estimate of the participant-average difference was 4.15 (95% confidence interval: -3.37 to 11.66), compared with 2.84 (95% confidence interval: -7.37 to 13.04) for the cluster-average independence estimating equation estimate, and 3.23 (95% confidence interval: -6.70 to 13.16) from a mixed-effects model. Similarly, for thromboembolic/ischaemic events, the independence estimating equation estimate for the participant-average odds ratio was 0.43 (95% confidence interval: 0.07 to 2.48), compared with 0.33 (95% confidence interval: 0.06 to 1.77) from the cluster-average estimator.
conclusionIn this re-analysis, we found that estimates from the various approaches could differ, which may be due to the presence of informative cluster size. Careful consideration of the estimand and the plausibility of assumptions underpinning each estimator can help ensure an appropriate analysis methods are used. Independence estimating equations and the analysis of cluster-level summaries (with appropriate weighting for each to correspond to either the participant-average or cluster-average treatment effect) are a desirable choice when informative cluster size is deemed possible, due to their unbiasedness in this setting.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.